Graeme Clark Collection
Permanent URI for this collection
Search Results
1 - 4 of 4
-
ItemThe University of Melbourne/Nucleus cochlear prosthesis( 1988)This is a review of research to develop the University of Melbourne/Nucleus cochlear prosthesis for patients with a profound-total hearing loss. A more complete review can be obtained in Clark et al. A prototype receiver-stimulator and multiple-electrode array developed at the University of Melbourne was first implanted in a postlingually deaf adult patient with a profound-total hearing loss on 1 August 1978. A speech processing strategy which could help this patient understand running speech, especially when combined with lipreading was developed in 1978 following initial psychophysical studies. A prototype wearable speech processor was fabricated in 1979, that could provide significant help for the first two patients in understanding running speech when used in combination with lipreading compared with lipreading alone, and it also enabled them to understand some running speech when using electrical stimulation alone. An implantable receiver-stimulator and wearable speech processor embodying the principles of the prototype devices were then produced for clinical trial by the Australian biomedical firm, Nucleus Ltd, and its subsidiaries, Cochlear Pty Ltd and Cochlear Corporation. This cochlear implant was initially clinically trialled on six patients at The Royal Victorian Eye & Ear Hospital in 1982, and shown to give similar results to those obtained with the prototype device. In view of these findings a clinical trial was carried out for a Premarket Approval Application to the US Food and Drug Administration (FDA), and extended to a number of centres in the US, Canada, and West Germany. This clinical trial confirmed that patients could understand running speech when electrical stimulation was combined with lipreading, and that some patients could also understand running speech when using electrical stimulation alone. Today, more than 600 patients world-wide are using cochlear implants developed from the research described in this paper.
-
ItemSurgery for an improved multiple-channel cochlear implant( 1984)An improved multiple-channel cochlear implant has been developed. The titanium container with enclosed electronics, the receiver coil and the connector are embedded in medical-grade Silastic. The upper half of the implant has a diameter of 35 mm and a height of 4.5 mm. and the lower half a diameter of 23 mm and a height of.5 mm. The electrode array has also been designed to reduce the possibility of breakage due to repeated movements over many years. The surgery involves drilling a bed in the mastoid bone for the receiver-stimulator, and fixing the proximal electrode under the mastoid cortex. Gentle insertion of the electrode array through the round window and along the seala tympani is achieved with a specially designed microclaw.
-
Item3D reconstruction of the temporal bone in cochlear implant surgery [Abstract]( 1991)High resolution CT-imaging is a routine part of the preoperative evaluation of prospective cochlear implant patients. We have used image analysis techniques to produce three-dimensional (3D) reconstruction of the temporal bone from serial CT-scans. These images have proved very useful in the examination of the temporal bone prior to implant surgery.
-
ItemSelection of patients for multiple-channel cochlear implantation(Raven Press, 1985)Only profoundly, bilaterally deaf adults are considered for evaluation. It is necessary to determine that the patient's communication ability cannot be improved to any significant degree with conventional hearing aids currently available. Initial assessment consists of audiometry, hearing aid evaluation(s), otological and medical examination, and for patients with no recent experience with hearing aids, a hearing aid trial. Polytome x-rays of temporal bones is carried out to ensure that cochlea structures are not grossly abnormal. Electrical stimulation of the promontory is used to confirm the presence of residual auditory nerve fibers. Where there is an audiometric difference between ears, the poorer ear is chosen for implantation provided there are no other contraindications. Intensive counselling is carried out to enable patients to make a fully informed decision about implantation. Patients undergo a battery of speech discrimination and lipreading tests with their hearing aid after their hearing aid trial. This is to provide a baseline for comparison with postoperative results and to assess the benefit obtained from the hearing aid. Any significant improvement in test results when using a hearing aid over lipreading alone would be a contraindication for implantation. Medical assessment is carried out as for any major surgery, including pathology, respiratory function tests and cardiovascular assessment. Particular emphasis is placed on infection prevention immediately preoperatively and during surgery.